Philip A Hines
Overview
Explore the profile of Philip A Hines including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vignali V, Hines P, Cruz A, Zietek B, Herold R
Front Med (Lausanne)
. 2022 Dec;
9:1064003.
PMID: 36569125
In medicines development, the progress in science and technology is accelerating. Awareness of these developments and their associated challenges and opportunities is essential for medicines regulators and others to translate...
2.
Hines P, Herold R, Pinheiro L, Frias Z, Arlett P
Nat Rev Drug Discov
. 2022 Nov;
22(2):81-82.
PMID: 36411368
No abstract available.
3.
Jansen E, Hines P, Berntgen M, Brand A
Value Health
. 2022 Apr;
25(10):1726-1735.
PMID: 35370077
Objectives: Access to medicines in Europe depends on a benefit-risk decision taken by regulators and a relative effectiveness assessment performed by health technology assessment bodies (HTABs) to inform, as one...
4.
Orellana Garcia L, Ehmann F, Hines P, Ritzhaupt A, Brand A
Front Med (Lausanne)
. 2021 Nov;
8:753187.
PMID: 34790681
An increasing number of medicines authorised in Europe recommend or require biomarker-based patient selection. For some of these the use of a companion diagnostic (CDx), a subset of diagnostics (IVDs),...
5.
Hines P, Agricola E, Llinares Garcia J, ODwyer L, Herold R
Nat Rev Drug Discov
. 2021 Jul;
21(1):1-2.
PMID: 34326503
No abstract available.
6.
Hines P, Gonzalez-Quevedo R, Lambert A, Janssens R, Freischem B, Torren Edo J, et al.
Front Med (Lausanne)
. 2020 Oct;
7:508.
PMID: 33072771
The pace of innovation is accelerating, and so medicines regulators need to actively innovate regulatory science to protect human and animal health. This requires consideration and consultation across all stakeholder...
7.
Hines P, Janssens R, Gonzalez-Quevedo R, Lambert A, Humphreys A
Nat Rev Drug Discov
. 2020 Apr;
19(5):293-294.
PMID: 32235873
No abstract available.
8.
Hines P, Guy R, Brand A, Humphreys A, Papaluca-Amati M
Br J Clin Pharmacol
. 2019 Aug;
86(12):2530-2534.
PMID: 31426120
Regulatory science underpins the objective evaluation of medicinal products. It is therefore imperative that regulatory science and expertise remain at the cutting edge so that innovations of ever-increasing complexity are...
9.
Hines P, Guy R, Humphreys A, Papaluca-Amati M
Nat Rev Drug Discov
. 2019 Jun;
18(6):403-404.
PMID: 31160761
No abstract available.